IL10 and neoplasm: Upon their recruitment to tumors, newly activated macrophages are reprogrammed by tumor-derived factors, including TGF-β, IL-10, and hypoxic signals, into a phenotype that aligns more closely with tissue repair and immune suppression than robust tumor clearance [50].